Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Show Therapeutic Classes
QR Code Add Formweb to your mobile device
Android iOS
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Search results for:

coagulation factor VIIa

coagulation factor VIIa
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
NovoSeven RT POWDER FOR INJECTION, INTRAVENOUS 1,000 mcg, 2,000 mcg, 5,000 mcg      
Comments:

Hemophilia Blood Factor Flow Diagram

NovoSeven is classified as restricted to use by cardiovascular surgeons, emergency department physicians, hematologists, neurologists, neurosurgeons, vascular surgeons, and trauma surgeons for any of the following situations:

  1. Emergent reversal of warfarin or oral direct factor Xa inhibitor induced serious, life-threatening bleeding in adults.
  2. For those adults on those anticoagulants requiring emergent surgery.
  3. Life-threatening bleeding unresponsive to alternative therapies.

 

Round weight based dosages to the nearest 1 mg.

 

 

Reviewed: October 2003, July 29, 2008 (NOVOSEVEN RT)

Updated: 25 April 2017, September 2021

 

Last updated: Feb. 25, 2026






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved